Taurunum Medical Journal
Sign in
Issue image

More articles from Volume 28, Issue 4, 2012

Delivery after assisted reproduction

Impact of medical therapy for sympthomatic benign prostatic hyperplasia on transurethral resection of the prostate

Dementia: Screening and early detection in General Practice -a Pilot Study

Deset godina posle -Izazovi u identifikaciji eshumiranih posmrtnih ostataka na teritoriji Kosova i Metohije

A retrospective analysis of transurethral vapor resection of the prostate versus transvesical prostatectomy for prostate greater than 50 ml

Article views


{{ submission.title }}

Impact of medical therapy for sympthomatic benign prostatic hyperplasia on transurethral resection of the prostate

Aleksandar Argirovic ,
Aleksandar Argirovic
View authors publications

Search this author on:

PubMed | Google Scholar
Djordje Argirovic
Djordje Argirovic
View authors publications

Search this author on:

PubMed | Google Scholar

Published: 01.12.2011.

Biochemistry

Volume 28, Issue 4 (2012)

pp. 733-740;

https://doi.org/10.5937/matmed1204733a

Abstract

References

1.
Girman C, Jacobsen S, Tsukamoto T. Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology. 1998;428–36.
2.
Flaniger R, Reda D, Wasson J, Anderson R, Abdellatif M, Bruskowitz R. 5-Year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study. J Urol. 1998;12–7.
3.
Sarma A, Jackobsen D, Mcgree M, Roberts R, Lieber M, Jacobsen S. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted Country, Minesota: 1987 to 1997. J Urol. 2005;2048–53.
4.
Mcconnell J, Bruskewitz R, Walsh P. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Eng J Med. 1998;557–63.
5.
Nickel J, Sander S, Moon T. A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to Benign Prostatic Hyperplasia. Int J Clin Pract. 2008;1547–59.
6.
Mcconnell J, Roehborn C, Bautista O. The long-term efficacy of doxazosin, finasteride, and combination therapy in the clinical progression of benign prostatic hyperplasia. N Eng J Med. 2003;2378–98.
7.
Roehborn C, Siami P, Barkin J. The effect of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4 year results from CombAT study. Eur Urol. 2010;123–31.
8.
Reich O, Gratzke C, Backmann A. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10.654 patients. J Urol. 2008;246–9.
9.
Borth C, Beiko D, Nickel J. Impact of medical therapy on transurethral resection of the prostate: a decade of change. Urology. 2001;1082–5.
10.
Dj A, Argirović A. Impact of preoperative administration of finasteride on perioperative bleeding during transurethral vapor resection of the prostate. Materia Medica. 2011;303–9.
11.
E-Mail.

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Partners
TT Medik
Google Schoolar
DOAJ